Search results: Sage Journals

Open accessReview articleFirst published 2026

Minocycline-containing therapy in Helicobacter pylori infection: a systematic review and meta-analysis

Zhihua Tian, Yanjiao Zhang, Nan Luo [...]

Therapeutic Advances in Gastroenterology

Free accessResearch articleFirst published January, 2014

Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial

Mohamed H. Emara, Salem Y. Mohamed, Hesham R. Abdel-Aziz

Therapeutic Advances in Gastroenterology

Restricted accessResearch articleFirst published June, 2000

Helicobacter Pylori Eradication in Clinical Practice: Retreatment Rates and Costs of Competing Regimens

Kathleen A Fairman, Brenda R Motheral

Annals of Pharmacotherapy

Restricted accessReview articleFirst published July, 2016

Similar Rate of Infection Eradication for Functional Articulating,Prefabricated and Custom-Made Spacers in 2-Stage Revision of the Infected Total Hip: A Literature Review

Ewout S. Veltman, Dirk Jan F Moojen, Mathias Glehr [...]

HIP International

Open accessResearch articleFirst published 2024

Ten-day vonoprazan–amoxicillin dual therapy versus 14-day esomeprazole–amoxicillin dual therapy for first-line Helicobacter pylori eradication: a prospective multicenter randomized controlled trial

Ben-Gang Zhou, Ming-Wen Guo, Li-Juan Zhang [...]

Therapeutic Advances in Gastroenterology

Open accessResearch articleFirst published September, 2024

Ten-day vonoprazan-based versus fourteen-day proton pump inhibitor-based therapy for first-line Helicobacter pylori eradication in China: A meta-analysis of randomized controlled trials

Wenwen Gao, Qian Wang, Xiang Zhang [...]

International Journal of Immunopathology and Pharmacology

Restricted accessMeeting reportFirst published July, 1994

Mathematical Examination of Dual Individualization Principles (II): The Rate of Bacterial Eradication at the Same Area under the Inhibitory Curve is More Rapid for Ciprofloxacin Than for Cefmenoxime

Thomas F. Goss, Alan Forrest, David E. Nix [...]

Annals of Pharmacotherapy

Open accessResearch articleFirst published 2022

High-dose dual therapy versus culture-based susceptibility-guided therapy as a rescue regimen for Helicobacter pylori infection: a randomized controlled trial

Zhe Zhao, Pei-Ying Zou, Na-Yun Su [...]

Therapeutic Advances in Gastroenterology

Restricted accessResearch articleFirst published December, 2016

Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection

K Manavi, N Hettiarachchi, J Hodson

International Journal of STD & AIDS

Open accessResearch articleFirst published 2025

Comparison of tegoprazan-based high-dose dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: a prospective,multicentre,randomised controlled trial in Gansu Province,a high-resistance region of China

Jinxia Yang, Xiuhong Zhang, Lihong Yang [...]

Therapeutic Advances in Gastroenterology

Open accessReview articleFirst published 2026

Minocycline-containing therapy in Helicobacter pylori infection: a systematic review and meta-analysis

Zhihua Tian, Yanjiao Zhang, Nan Luo [...]

Therapeutic Advances in Gastroenterology

Free accessResearch articleFirst published January, 2014

Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial

Mohamed H. Emara, Salem Y. Mohamed, Hesham R. Abdel-Aziz

Therapeutic Advances in Gastroenterology

Restricted accessResearch articleFirst published June, 2000

Helicobacter Pylori Eradication in Clinical Practice: Retreatment Rates and Costs of Competing Regimens

Kathleen A Fairman, Brenda R Motheral

Annals of Pharmacotherapy

Restricted accessReview articleFirst published July, 2016

Similar Rate of Infection Eradication for Functional Articulating,Prefabricated and Custom-Made Spacers in 2-Stage Revision of the Infected Total Hip: A Literature Review

Ewout S. Veltman, Dirk Jan F Moojen, Mathias Glehr [...]

HIP International

Open accessResearch articleFirst published 2024

Ten-day vonoprazan–amoxicillin dual therapy versus 14-day esomeprazole–amoxicillin dual therapy for first-line Helicobacter pylori eradication: a prospective multicenter randomized controlled trial

Ben-Gang Zhou, Ming-Wen Guo, Li-Juan Zhang [...]

Therapeutic Advances in Gastroenterology

Open accessResearch articleFirst published September, 2024

Ten-day vonoprazan-based versus fourteen-day proton pump inhibitor-based therapy for first-line Helicobacter pylori eradication in China: A meta-analysis of randomized controlled trials

Wenwen Gao, Qian Wang, Xiang Zhang [...]

International Journal of Immunopathology and Pharmacology

Restricted accessMeeting reportFirst published July, 1994

Mathematical Examination of Dual Individualization Principles (II): The Rate of Bacterial Eradication at the Same Area under the Inhibitory Curve is More Rapid for Ciprofloxacin Than for Cefmenoxime

Thomas F. Goss, Alan Forrest, David E. Nix [...]

Annals of Pharmacotherapy

Open accessResearch articleFirst published 2022

High-dose dual therapy versus culture-based susceptibility-guided therapy as a rescue regimen for Helicobacter pylori infection: a randomized controlled trial

Zhe Zhao, Pei-Ying Zou, Na-Yun Su [...]

Therapeutic Advances in Gastroenterology

Restricted accessResearch articleFirst published December, 2016

Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection

K Manavi, N Hettiarachchi, J Hodson

International Journal of STD & AIDS

Open accessResearch articleFirst published 2025

Comparison of tegoprazan-based high-dose dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: a prospective,multicentre,randomised controlled trial in Gansu Province,a high-resistance region of China

Jinxia Yang, Xiuhong Zhang, Lihong Yang [...]

Therapeutic Advances in Gastroenterology